XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ (3,005,109) $ 1,034,440
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 2,290,130 2,456,590
Amortization of operating lease right-of-use assets 570,369 468,359
Share-based compensation 150,712 188,034
Decrease in non-cash contingent consideration (442,321) (476,606)
Increase in cash surrender value of life insurance policies over premiums paid (101,538) (95,997)
Increase in noncash interest expense 8,654 7,809
Net changes in assets and liabilities affecting operating activities:    
Accounts receivable (1,861,587) 944,925
Inventories 1,243,245 (232,110)
Other current assets and other assets 424,684 808,699
Operating lease liabilities (429,064) (1,042,792)
Accounts payable and other current liabilities (1,925,886) 386,614
Other long-term liabilities 85,404 (630,813)
Net cash provided by (used in) operating activities (2,992,307) 3,817,152
Cash flows from investing activities:    
Additions to property and equipment (48,799) (179,453)
Additions to intangible assets (56,191) (91,808)
Net cash used in investing activities (104,990) (271,261)
Cash flows from financing activities:    
Borrowings on line of credit 22,000,000 16,000,000
Payments on line of credit (18,692,552) (19,051,875)
Cash settlement of contingent consideration (813,478) (1,652,990)
Payments made in connection with repurchase of common shares (381,851) (349,910)
Net cash provided by (used in) financing activities 2,112,119 (5,054,775)
Net decrease in cash and cash equivalents (985,178) (1,508,884)
Cash and cash equivalents at beginning of period 18,321,624 19,757,970
Cash and cash equivalents at end of period $ 17,336,446 $ 18,249,086